AI assistant
Sending…
MANNKIND CORP — Director's Dealing 2018
Feb 28, 2018
31835_dirs_2018-02-27_e77542ec-8695-494c-987f-97ca23fb1467.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MANNKIND CORP (MNKD)
CIK: 0000899460
Period of Report: 2018-02-12
Reporting Person: Kendall David M (Chief Medical Officer)
More from MANNKIND CORP
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26